Introduction
============

An angiomyolipoma is a rare benign mesenchymal tumor composed of a mixture of smooth muscle cells, blood vessels and a variable amount of fat. The appearance of an angiomyolipoma has often been reported in the kidney but rarely in the liver. The first hepatic angiomyolipoma was described by Ishak in 1976 \[[@B1]\]. It can be found in both men and women, most commonly in adult women. The majority of patients with hepatic angiomyolipoma are asymptomatic. Others suffer from abdominal pain and mild fever \[[@B2]\]. There is no histological difference between an angiomyolipoma of the liver or the kidney. A differentiation of malignant liver tumors is often very difficult because of the high variability of the fat proportion.

Case presentation
-----------------

A 43-year-old Caucasian man was found to have a large echogenic mass in his right liver lobe by abdominal ultrasonography. The hepatic lesion measured about 5 × 9 cm with a well-demarcated border (Figure [1A](#F1){ref-type="fig"}). Color Doppler imaging showed intense vascularization in the periphery of the tumor (Figure [1B](#F1){ref-type="fig"}). Five months prior to admission, our patient had noticed chronic fatigue, a loss of efficiency and abdominal stress under his right costal arch. A physical examination was unremarkable. Serum biochemistry tests were without any pathological findings. The serologic assay for viral hepatitis B and C were negative. The serum alpha-fetoprotein level was 1.5 ng/mL (normal range \< 6 ng/mL). Magnetic resonance imaging (MRI; 1.5T Magnetom Avanto, Siemens Medical Solutions, Erlangen, Germany) of the liver mass using a native fat-suppressed T1-weighted gradient echo sequence showed a fat-equivalent signal behavior comparable to that of the subcutaneous adipose tissue (Figure [1C](#F1){ref-type="fig"}). A contrast-enhanced ultrasonography (CEUS; Acuson Sequoia, Siemens Medical Solutions) was performed for further information. It revealed a well-demarcated hyperechoic liver mass in segment VI, measuring 9.7 × 9.2 × 5.4 cm in maximum diameter with a hypoechogenic portion. The margin was well defined and smooth. The contrast agent (SonoVue, Bracco International, Amsterdam, Netherlands) showed a hyperperfusion from the early to the late vascular phase in comparison with the surrounding liver tissue. There was no sign of \"halo\" or \"nodule-in-nodule\" formation (Figure [1D](#F1){ref-type="fig"}).

![**Radiological and histopathological characterization of hepatic angiomyolipoma**. (A) Detection of a hepatic lesion by abdominal ultrasonography. (B) Color Doppler examination showing peripheral hypervascularization. (C) Typical MRI aspects of hepatic angiomyolipoma. (D) CEUS findings. (E) Gross pathological findings after surgery. (F) Histological demonstration of mostly adipose tissue. (G) Demonstration of epithelioid cells typically arranged around blood vessels. (H) Positive immunohistochemistry for the melanoma marker HMB-45.](1752-1947-5-481-1){#F1}

After presenting all imaging results in an interdisciplinary liver conference, an atypical resection of the right lobe of his liver was recommended. Our patient underwent surgery without any problems. After nine days, he left the hospital in good clinical condition. The macroscopic examination revealed a solitary tumor with a mottled yellow color and a soft consistency in the right lobe of his liver (Figure [1E](#F1){ref-type="fig"}). The microscopic examination showed that the tumor was well circumscribed but non-encapsulated and consisted mostly of adipose tissue with solid areas of elongated and rounded epithelioid cells, often arranged around thick-walled blood vessels (Figure [1F](#F1){ref-type="fig"} and [1G](#F1){ref-type="fig"}). In the solid areas, the cells expressed smooth muscle actin and the melanoma marker HMB-45 (Figure [1H](#F1){ref-type="fig"}). Extramedullary hematopoiesis was not observed. A diagnosis of hepatic angiomyolipoma was made. Six months after surgery our patient is in good clinical condition. Chronic fatigue and loss of efficiency have disappeared. Abdominal ultrasonography and serum biochemistry tests were without any pathological findings.

Discussion
==========

Hepatic angiomyolipoma has been considered as a benign disease in the past. However, spontaneous tumor rupture, malignant transformation and recurrence after primary resection, as well as concurrent hepatic angiomyolipoma and hepatocellular carcinoma, have been reported \[[@B3],[@B4]\]. Surgical resection should be considered for all symptomatic patients. Conservative management with close follow-up is suggested in patients with asymptomatic tumors, good compliance and absence of hepatitis virus infection, as well as small hepatic angiomyolipoma (\< 5 cm) that are diagnosed through fine-needle aspiration biopsy \[[@B5]\].

Because of the variable amount of adipose tissue in hepatic angiomyolipoma, it is sometimes difficult to distinguish between benign and malignant tumors. It is possible to misdiagnose hepatic angiomyolipoma as lipoma, hepatocellular adenoma or carcinoma, sarcoma or metastasis before surgery. Contrast-enhanced spiral computed tomography shows a marked enhancement in the arterial and the portal venous phase of the soft tissue components \[[@B5]\]. Recently, CEUS has been shown to demonstrate typical imaging characteristics of hepatic angiomyolipoma; an inhomogeneous hyperenhancing pattern in arterial phase, prolonged hyperenhancing during portal and late phase, with a smooth and well-defined margin \[[@B6]\]. MRI is considered the best imaging method to identify an angiomyolipoma. It shows a hyperintensity on T2-weighted images and a hypointensity on T1-weighted images, according to the amount of adipose tissue \[[@B5]\].

Conclusion
==========

Although the combination of various imaging modalities increases preoperative diagnostic accuracy it is reported to be less than 25% \[[@B7]\]. A definitive diagnosis is only given by a histological examination after surgery. Identification of smooth muscle cells, blood vessels and adipose tissue with a positive immunohistochemical reaction for HMB-45 is the final evidence for an angiomyolipoma \[[@B8]\].
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